# Resperine, Gabapentin, or Lamotrigine for the Treatment of Cocaine Dependence: 2 - 7

> **NCT00015106** · PHASE2 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)**

## Conditions studied

- Cocaine-Related Disorders

## Interventions

- **DRUG:** Lamotrigine

## Key facts

- **NCT ID:** NCT00015106
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-11
- **Primary completion:** 1999-01
- **Final completion:** 1999-02
- **Target enrollment:** 0 (—)
- **Last updated:** 2017-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00015106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00015106, "Resperine, Gabapentin, or Lamotrigine for the Treatment of Cocaine Dependence: 2 - 7". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00015106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*